Overview
Xiaopan Xu practices practicing medicine in Xi'an, China.
Xu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Bladder Cancer, Glioblastoma, Astrocytoma, and Non-Muscle Invasive Bladder Cancer.
They are actively involved in clinical research, co-authoring 27 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaopan Xu
Is Xiaopan Xu a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaopan Xu is classified as an Advanced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaopan Xu participate in research or clinical trials?
Yes. Xiaopan Xu has published 27 articles and abstracts on conditions like Bladder Cancer. You can view a list of Xiaopan Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bladder CancerXu isAdvanced. Learn about Bladder Cancer.
- Experienced
- AstrocytomaXu isExperienced. Learn about Astrocytoma.
- GlioblastomaXu isExperienced. Learn about Glioblastoma.
- GliomaXu isExperienced. Learn about Glioma.
- Non-Muscle Invasive Bladder Cancer